Status:
UNKNOWN
Golden Walk as Measure of Gait Rehabilitation in Parkinson's Disease
Lead Sponsor:
I.R.C.C.S. Fondazione Santa Lucia
Collaborating Sponsors:
University of Roma La Sapienza
Università degli studi di Roma Foro Italico
Conditions:
Rehabilitation
Parkinson Disease
Eligibility:
All Genders
40-85 years
Phase:
NA
Brief Summary
Gait is specifically impaired in Parkinson's disease (PD). External auditory cue based on a binary rhythm tested in PD patients disappear when the stimulus is removed. Golden Ratio (GR)is intrinsic in...
Detailed Description
Gait is specifically impaired in Parkinson's disease (PD). External auditory cue based on a binary rhythm has been successfully used in people with PD to improve their gait quality, but the beneficial...
Eligibility Criteria
Inclusion
- diagnosis of idiopathic PD, as proposed by the Brain Bank Criteria for PD, since at least 5 years
- suffered from a rigid akinetic form of bilateral Parkinson's Disease (Hoehn and Yahr: 2-3), according to current criteria
- to be on stable treatment regimen for at least the 3 months before the recruitment
- Mini Mental State Examination score \>24
- Do not vary the pharmacological treatment during the entire duration of the study
- Be tested in "ON" medication state
Exclusion
- inability to stand or walk without aids or supports
- factors affecting gait such as hip replacement, musculoskeletal disorders, uncorrected vision or vestibular problems;
- inability to follow instructions;
- severe dysautonomia with marked hypotension, major depression, dementia, pregnancy, or cardiac pacemaker
Key Trial Info
Start Date :
June 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04706572
Start Date
June 15 2020
End Date
June 1 2022
Last Update
January 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Santa Lucia
Rome, Lazio, Italy, 00179